source
- AstraZeneca and Bristol Myers Squibb rumored to be in talks for a major mergerOver the weekend, reports emerged that AstraZeneca and Bristol Myers Squibb were reportedly discussing a possible merger. Industry observers note that such a combination would create one of the la…
- Pfizer drops two obesity programs, including Metsera-derived GLP-1 candidate, in pipeline cleanoutPfizer announced it is removing two clinical‑stage obesity programs as part of its quarterly pipeline cleanout. The first program, MET-224o, is an oral ultra‑long‑acting GLP‑1 receptor agonist tha…